James H. Stein, MD

• Professor, Department of Medicine
• Cardiovascular Medicine Division
• University of Wisconsin School of Medicine and Public Health
• Director, Preventive Cardiology
• University of Wisconsin Hospital and Clinics
• Madison, WI

 

Research Topics

• Director, UW Atherosclerosis Imaging Research Program, which currently is the Carotid Ultrasound Reading Center for MESA and the Brachial Artery Reactivity Testing Reading Center for the NHLBI HIV-CVD Initiative
• Ultrasound assessment of carotid atherosclerosis, endothelial function, and clinical trials in preventive cardiology
• Detection and characterization of subclinical atherosclerosis in individuals with sleep apnea, tobacco use, diabetes mellitus, and human immunodeficiency virus (HIV), and the use of CIMT measurements for cardiovascular disease risk prediction

 

Lecture and Writing Topics

• HIV, ART, and CVD risk
• HIV, ART, and dyslipidemia
• CVD risk assessment
• Lipid management
• CVD biomarkers
• Atherosclerosis imaging

 

Current Professional Summary

Dr Stein is a Professor of Medicine in the Division of Cardiovascular Medicine at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. He is Director of the Preventive Cardiology Program and Director of the Vascular Health Screening Program at the University of Wisconsin Hospital and Clinics. He also is Associate Director of the Adult Echocardiography Laboratory and Director of the UW Atherosclerosis Imaging Research Program. He is a practicing clinical cardiologist and preventive cardiologist.

 

Committees and Organizations

• Chairman, HIV Medical Association/Infectious Disease Society of America Guidelines Committee for the Evaluation and Management of Dyslipidemia in HIV-Infected Adults Receiving Antiretroviral Therapy
• Steering Committees and Data Monitoring Committees for several multi-center studies
• Ad Hoc Reviewer, National Institutes of Health
• Co-Author, American Society of Echocardiography Recommendations for Use of Echocardiography in Clinical Trials
• Chairman, American Society of Echocardiography Carotid IMT Writing Group and their Consensus Statement on "Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk"

 

Honors and Awards

Dr Stein received the American College of Cardiology W. Proctor Harvey Young Teacher Award for Excellence in Teaching in 2001. Dr Stein frequently has been named one of Madison's "Top Docs" in Cardiology by Madison Magazine since 2000. He has been listed in “Best Doctors in America” since 2007. In 2007, he was named one of the 20 best cardiologists in America by Men's Health Magazine. In 2008, he was named one of the 20 best cardiologists in America by Women's Health Magazine.

 

Education

• University of Wisconsin, BS with Honors
• Yale University School of Medicine, MD (cum laude)
• University of Chicago Medical Center, Internship, Internal Medicine
• University of Chicago Medical Center, Residency, Internal Medicine
• Rush-Presbyterian-St. Luke's Medical Center, Fellowship, Cardiology

 

Selected Publications

1. Murphy RL, Berzins B, Zala C, et al. Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy. AIDS. 2010;24:885-890.
2. Stein JH, Currier JS. Risk of myocardial infarction and nucleoside analogues. Lancet. 2008;371:1391-1392.
3. Stein JH, Hadigan CM, Brown TT, et al. Prevention strategies for cardiovascular disease in HIV-infected patients. Circulation. 2008 Jul 8;118(2):e54-e60.
4. Stein JH, Komarow L, Cotter BR, et al. Lipoprotein changes in HIV-infected antiretroviral-naïve individuals after starting antiretroviral therapy: ACTG Study A5152s Stein: lipoprotein changes on antiretroviral therapy. J Clin Lipidol. 2008;2:464-471.
5. Torriani FJ, Komarow L, Parker RA, et al. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008;52:569-576.
6. Stein JH. Cardiovascular risks of antiretroviral therapy. N Engl J Med. 2007;356:1773-1775.
7. Dubé MP, Wu JW, Aberg JA, et al. Safety and efficacy of extended-release niacin for the treatment of dyslipidaemia in patients with HIV infection: AIDS Clinical Trials Group Study A5148. Antivir Ther. 2006;11:1081-1089.
8. Stein JH, Merwood MA, Bellehumeur JB, McBride PE, Wiebe DA, Sosman JM. Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection. Arterioscler Thromb Vasc Biol. 2005;25:399-405.
9. Stein JH, Merwood MA, Bellehumeur JL, et al. Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors. Am Heart J. 2004;147:E18.
10. Stein JH, Klein MA, Bellehumeur JL, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation. 2001;104:257-262.